Sublethal ischemia leads to increased tolerance against subsequent prolonged cerebral ischemia in vivo. In the present study, we investigated the roles of the astrocytic glutamate (Glu) transporter GLT-1 in preconditioning (PC)-induced neuronal ischemic tolerance in cortical neuron/astrocyte co-cultures. Ischemia in vitro was simulated by subjecting cultures to both oxygen and glucose deprivation (OGD). A sublethal OGD (PC) significantly increased the survival rate of neurons when cultures were exposed to a lethal OGD 24 hr later. The extracellular concentration of Glu increased significantly during PC, and treatment with an inhibitor of NMDA receptors significantly reversed the PC-induced ischemic tolerance of neurons, suggesting that the increase in extracellular concentration of Glu during PC was critical to the development of PC-induced neuronal ischemic tolerance via the activation of NMDA receptors. Treatment with a GLT-1 blocker during PC significantly suppressed this increase in Glu, and antagonized the PC-induced neuronal ischemic tolerance. This study suggested that the reversed operation of GLT-1 was crucial to the development of neuronal ischemic tolerance.
Introduction
Extracellular L-glutamate (Glu) in the mammalian brain is subject to homeostasis because an elevated concentration results in the excessive activation of Glu receptors, thereby resulting in neuronal death (Choi, 1988) . Astrocytes seem to be the cell type primarily responsible for the clearance of extracellular Glu in the brain (Rothstein et al., 1996) , while the astrocytic Na + -dependent Glu transporter GLT-1 is quantitatively the dominant form (Rao et al., 1996; Tanaka et al., 1997) . Thus, the normal function of astrocytic Glu transporters is believed to be crucial to the survival of neurons in the brain. However, under certain conditions such as brain ischemia, the role of astrocytic Glu transporters is reversed; that is, Glu is released from astrocytes to the extracellular space (Szatkowski et al., 1990) , triggering the death of neurons.
Recently however, Rossi and his collegues (2000) have reported that the reversed uptake of Glu by neuronal Glu transporters is crucial in the death of neurons during ischemia. Therefore, it remains controversial as to what mechanisms are critical for the ischemia-induced rise of Glu and neuronal death.
Preconditioning (PC) to ischemic tolerance is a phenomenon in which a brief subtoxic insult induces robust protection against the deleterious effects of a subsequent, prolonged, lethal 4 ischemia (Nandagopal et al., 2002) . In the brain, Kitagawa and his collegues (1990) first reported that gerbils subjected to a sublethal transient global ischemia exhibited reduced hippocampal neuronal death after a more severe ischemic insult 24~28 hr later. Since then, numerous studies have been performed on this phenomenon, but the mechanistic basis of PC-induced ischemic tolerance has not been fully delineated.
Here we provide experimental evidence that the reversed uptake of Glu via the astocytic Glu transporter GLT-1 during PC was crucial to the development of PC-induced neuronal ischemic tolerance.
Materials and Methods
The animal experiments conformed to the "Principles of laboratory animal care" (NIH publication No. 85-23, revised 1996) , as well as the "guide for the care and use of laboratory animals", Hokkaido University School of Medicine (Hokkaido, Japan).
Cell culture.
Culture methods were described elsewhere in detail (Kawahara et al., 2002b; 2004) . In brief, neurons/astrocytes were prepared from 16 to 18 day old embryonic rat cortices and grown in Dulbecco's modified Eagle's medium (DMEM, Gibco, Grand Island, NY) which was supplemented with 10 % heat-inactivated fetal bovine serum (FBS), 10 % Ham's F12, and 0.24 % penicillin/streptomycin (culture medium). Cells were plated at a uniform density of 3.0 ×10 5 cells/cm 2 onto poly-L-lysine (100 μg/ml)-coated plastic dishes and maintained in a 5 % CO 2 incubator at 37 ℃. The cultures were fed a filtered (0.22 μm; Millipore, Bedford, TX) conditioned medium (CM) twice a week. To obtain the CM, cells from the 16-18 day old embryonic rat cortices were plated onto poly-L-lysine-coated 6-well dishes and cultured for more than 2 weeks. The cultures were then fed a cooled culture medium and incubated for an 6 additional day. The culture medium was then filtered and used as a CM. After 13-15 days, the neurons in these cultures sit on the top of a confluent monolayer of astrocytes. The experiments were performed using these cultures.
Immunocytochemistry.
Astrocytes and neurons were identified by immunostaining with antibodies against glial fibrillary acidic protein (GFAP; Sigma, St Louis, MO) and microtubule-associated protein 2 (MAP-2; Sigma), respectively. The astrocytic glutamate transporters GLT-1 and GLAST were detected by immunostaining with anti-GLT-1 and anti-GLAST polyclonal antibodies (Chemicon, Temecula, CA), respectively. The neuronal glutamate transporter EAAC1 was also detected with anti-EAAC1 polyclonal antibody (Sigma). For the labeling of MAP-2, GFAP, GLAST, GLT-1, and EAAC1, the cortical cells were fixed with 4 % paraformaldehyde for 5 minutes at 4 ℃, followed by 95 % methanol in PBS for 10 minutes at -20 ℃. The cells were then incubated with a primary antibody over a 24 hour period using a dilution of 1:1000 for MAP-2, 1:400 for GFAP, 1:400 for GLT-1, 1:5000 for GLAST, and 1:400 for EAAC1. After being washed with phosphate-buffered saline (PBS), the cells were incubated with a secondary antibody containing 1.0 % goat serum for 30 minutes. For labeling, a 1:500 dilution of biotinylated goat antibody against mouse IgG (Vector Laboratories, Burlingame, CA) was used.
Bound antibodies were detected by the avidin-biotin-peroxidase complex (ABC) method, using a commercial ABC kit (Vector Laboratories). Observation of peroxidase activity was made possible by incubation with 0.1 % 3,3'-diaminobenzidine tetrahydrochloride (DAB) in a 50 mM 
Oxygen-Glucose deprivation.
Cortical cultures were subjected to oxygen-glucose deprivation (OGD) injury using a protocol described previously (Kawahara et al., 2002a; 2004) . In brief, cultures were placed in an anaerobic chamber and washed two times with a balanced salt solution (BSS: 116 mM NaCl, 0.8 mM MgSO 4 , 5.4 mM KCl, 1.0 mM NaH 2 PO 4 , 26.2 mM NaHCO 3 , 1.8 mM CaCl 2 , 0.01 mM glycine, and 10 mg/l phenol red) lacking glucose. Near anoxic conditions were achieved using an Anaero-Pack System (Mitsubishi Gas Chemical, Tokyo, Japan). After pre-gassing with 8 95 % N 2 -5 % CO 2 for at least 5 min to remove residual oxygen, glucose-free BSS was added to the cells, which were then placed in a purpose-built sealed chamber containing the deoxygenation reagent (Kenki for Cells, Mitsubishi Gas Chemical). The catalytic reaction of the reagent resulted in the consumption of O 2 and production of CO 2 . This Anaero-Pack System provided near anaerobic conditions with an O 2 concentration of < 1 % and a CO 2 concentration of about 5 % within 1 h of incubation at 37 ℃. Cells were exposed to these conditions for a designated period to produce either mild (sublethal) or lethal OGD. To terminate OGD, cultures were carefully washed with glucose (20 mM) containing BSS, and then incubated again in culture medium at 37 ℃ in 95 % air-5 % CO 2 (reperfusion). Cultures with sham treatment not deprived of oxygen and glucose were placed in BSS containing 20 mM glucose. In some experiments, BSS was prepared with no added calcium salts and the addition of 2 mM EGTA and 1.8 mM MgCl 2 . For the measurement of the NADH fluorescence, cultures were washed two times with BSS without glucose and phenol red. After washing, glucose-free BSS (containing with GDH 50 U/mL, NAD + 2 mM, GPT 4 U/mL, L-Alanine 2 mM) without phenol red was added to the cultures. The cultures were then placed in an own-made sealed chamber made of acrylic resin and glass for transmitting UV light containing the deoxygenation 9 reagent, and were placed on the fluorescent microscope (Olympus, IX70, Tokyo, Japan).
Measurement of the extracellular glutamate concentration
The extracellular concentration of glutamate (Glu) was measured using an enzymatic assay (Innocenti et al., 2000; Maguire et al., 1998) . In the presence of Glu and β 
Survival rate of neurons.
Neuronal death was analyzed following observation of the nuclear morphology using the fluorescent DNA-binding dyes, Hoechst 33342 (H33342) and propidium iodide (PI). Cells were incubated with these dyes for 15 minutes at 37℃. Individual nuclei were observed using fluorescent microscopy (Olympus, IX70, Tokyo, Japan) and subsequently analyzed. PI was used to identify nonviable cells. More specifically, an average of 450-500 neurons from random fields were analyzed in each experiment. The survival rate of neurons --meaning the percentage of viable neurons remaining --was determined by placing images of nuclear staining on phase-contrast images, and calculating (viable neurons/total neurons before drug treatment)
× 100, since some neurons came off the dishes at the time of inspection. At least 4 independent experiments (n ≧4) were conducted and analyzed.
Chemicals.
Dihydrokainate (DHK), bisbenzimide (Hoechst 33342),
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DL-2-amino-5-phosphonopentanoic acid (AP5), and propidium iodide (PI) were obtained from
Sigma. DL-threo-β-benzyloxyaspartate (TBOA) was purchased from Tocris (Avonmouth Bristol, UK). All other compounds were obtained from Wako Chemical (Tokyo, Japan).
Statistics.
Data are represented as the mean±S.D. Inter-group comparisons were made using the one-way analysis of variance (ANOVA) followed by a paired t-Test. Differences with a value of P＜0.01 or P＜0.05 were considered significant.
Results
We analyzed the role of the astrocytic glutamate (Glu) transporter GLT-1 in the preconditioning-induced ischemic tolerance of neurons in mixed cultures of neurons and astrocytes ( Fig. 1A1 & A2 ) from fetal rat brain (embryonic day 17). We first confirmed whether sublethal oxygen-glucose deprivation (OGD) induced neuronal ischemic tolerance in these cultures. We adopted a 60-70 min OGD as the preconditioning (PC), and 90-120 min OGD as the lethal insult (Kawahara et al., 2004) . Cultures were preconditioned with the sublethal OGD and then exposed to the lethal OGD 24 h later, since the time interval of 24 h between the PC and the lethal OGD induces maximal protective effect on neurons (Kawahara et al., 2004) . Exposure to OGD for 90 min produced massive neuronal death without glial degeneration when examined 24 h later ( Fig. 1B and F) . However, exposure of preconditioned cultures to lethal OGD 24 h later resulted in a significant increase in the survival rate of neurons inspected 24 h after the end of the lethal insult ( Fig. 1C and F) . Previous studies (Grabb and Choi, 1999; Kato et al., 1992) have suggested that the activation of NMDA receptors of neurons is essential to the PC-induced ischemic tolerance of neurons. Thus, we then investigated whether the activation of NMDA receptors was also involved in the neuronal ischemic tolerance 13 in our culture system. Treatment of cultures with AP5 (100μM) during the sublethal OGD (PC) significantly reversed the PC-induced ischemic tolerance of neurons ( Fig. 1D & 1F ).
Exposure to NMDA (10 μM) for 60 min without sublethal OGD emulated the PC-induced neuronal ischemic tolerance ( Fig. 1E & 1F) . These results indicated that a sublethal ischemic insult (PC) activated neuronal NMDA receptors, and contributed to the development of the PC-induced ischemic tolerance of neurons.
We then investigated whether the extracellular concentration of Glu actually increased during sublethal OGD (PC) for the activation of NMDA receptors. Exposure to OGD resulted in a significant increase in extracellular Glu about 40 min after the onset of an OGD insult ( Fig. 2A & 2C), but sham treatment did not ( Fig. 2B & 2C) . We have previously revealed that a sublethal OGD for 60-70 min was necessary for induction of the PC-induced ischemic tolerance of neurons (Kawahara et al., 2004) . Thus, the extracellular Glu concentration was significantly elevated during a sublethal OGD insult for the activation of NMDA receptors.
We then investigated the possible sources of Glu efflux during a sublethal OGD insult in the neuron/astrocyte co-cultures. The possibility that dead neurons and/or astrocytes were lysed, resulting in the escape of cytoplasmic Glu (Pellegrini-Giampietro et al., 1990; Phillis et 14 al., 1994) was excluded, since a careful inspection of the cultures at 60-70 min after the start of OGD (sublethal OGD) indicated that neither neurons nor astrocytes were degenerated at all (Fig.   2D1-D3) . Thus, there are at least two possible sources of Glu efflux: one is the Ca 2+ -dependent release from glutaminergic nerve endings (Drejer et al., 1985; Katayama et al., 1991) , and the other is the reversed operation of neuronal and/or astrocytic Glu reuptake transporters (Phillis et al., 2000; Roettger and Lipton, 1996; Szatkowski et al., 1990) .
We first tested whether the Ca 2+ -dependent Glu release was involved in the marked elevation of the extracellular concentration of Glu during PC. Even when the cultures were incubated in a solution containing EGTA (2 mM) and no added Ca 2+ , sublethal OGD produced a significant elevation in extracellular Glu with a similar time course as that of cultures incubated in a solution containing Ca 2+ (Fig. 3C, 3E & 3F) . This result suggested a minor contribution of Ca 2+ -dependent Glu release from nerve endings in the sublethal OGD-induced accumulation of extracellular Glu.
We next investigated the possible involvement of the reversed operation of Glu
transporters. An immunocytochemical analysis using anti-EAAC1, -GLT-1, and -GLAST antibodies demonstrated that both GLT-1 and GLAST were present on cultured astrocytes, but a neuronal Glu transporter EAAC1 was weakly stained (Fig. 3A) in the neuron/astrocyte co-cultures used here. Treatment of cultures with TBOA, a non-transportable inhibitor of Glu transporters (Shimamoto et al., 1998) , significantly suppressed the OGD-induced increase in the extracellular concentration of Glu (Fig. 3D, 3E, & 3F) . The concentration of TBOA was set at 50 μM, since this level provided maximal protection from ouabain-induced massive neuronal death (Kawahara et al., 2002b) . The result suggested that the reversed operation of Glu transporters was responsible for the OGD-induced Glu increase. Since TBOA is a non-specific blocker of Glu transporters, we cannot determine which transporters contributed most to the Glu elevation during PC. We previously demonstrated that the reversed operation of astrocytic GLT-1 is crucially involved in the ouabain-induced massive neuronal death in neuron/astrocyte mixed cultures (Kawahara et al., 2002b) . Thus, we next investigated whether the reversal contributed to the sublethal OGD-induced rise in Glu.
Treatment of cultures with DHK (200 μM), a selective blocker of astrocytic GLT-1 (Levy et al., 1998; Rao et al., 2001; Robinson, 1998) , resulted in a significant suppression of the OGD-induced increase in extracellular Glu (Fig. 4A & 4B) , suggesting that the reversed operation of astrocytic GLT-1 was essentially responsible for the rise in extracellular Glu during sublethal OGD (PC). If this is the case, DHK treatment during PC is expected to attenuate the PC-induced ischemic tolerance of neurons. We next tested this possibility. Expectedly, treatment of neuron/astrocyte mixed cultures with DHK during sublethal OGD significantly antagonized the PC-induced neuronal ischemic tolerance (Fig. 4D & 4E) , suggesting that the reversed operation of astrocytic GLT-1 was critical to the development of PC-induced ischemic tolerance of neurons. Treatment of cultures with the same concentration of DHK (200 μM)
for 70 min without OGD did not induce the significant death of neurons (Fig. 4F) .
A previous study has revealed that chronic exposure of cultured astrocytes to the antagonist of γ-aminobutyric acid (GABA) transporters increases the expression of GABA transporters (Bernstein and Quick, 1999) . This raises the possibility that chronic blockade of GLT-1 with DHK for 60-70 min would increase the expression of GLT-1, and hence would result in the greater release of Glu during OGD 24 h later via reversed operation of GLT-1. We finally investigated this possibility. An immunohistochemical staining of mixed neuron/astrocyte cultures for GLT-1 revealed that treatment with DHK (200 μM) for 70 min did not result in the detectable increase in the expression of astrocytic GLT-1 24 h later (Fig.   5D ). In addition, there was not a significant difference in the survival rate of neurons caused by OGD for 90 min between the cultures with-and without DHK pre-treatment for 70 min ( Fig.   5A-C) . These results suggested that the attenuation of PC-induced ischemic tolerance of neurons caused by treatment with DHK during sublethal OGD (Fig. 4) was not due to DHK-induced changes in the astrocytic GLT-1 expression.
Discussion
It has been generally believed that the reversed uptake of Glu by neuronal and/or astrocytic Glu transporters is the primary cause of ischemia-induced massive neuronal death (Phillis et al., 2000; Roettger and Lipton, 1996; Szatkowski and Attwell, 1994; Szatokowski et al., 1990) . The present study demonstrated for the first time, to the best of our knowledge, that the reversed operation of the astrocytic Glu transporter GLT-1 was critical to the preconditioning (PC)-induced ischemic tolerance of neurons.
In the mixed neuron/glia cultures used in this study, GLT-1-positive astrocytes were preferentially identified in astrocytes underneath the aggregate of neurons (Fig. 3A2) . A previous study has revealed that astrocytes co-cultured with neurons change from a polygonal to a process-bearing morphology that is more characteristic of astrocytes in situ (Swanson et al., 1997) . The expression of astrocytic GLT-1 increases with such morphological changes of astrocytes (Gegelachvilli et al., 1997) . These results suggest that neurons are directly involved in regulating the expression of GLT-1 (Gegelachvilli et al., 1997; Perego et al., 2000; Schlag et al., 1998) . This might be one of the reasons why GLT-1-positive astrocytes were preferentially identified on cells underneath neuronal aggregates in our mixed cultures.
Previous studies reported that ischemic stress to the brain or brain cell cultures induces a biphasic increase in the extracellular concentration of Glu Szatkowski and Attwell, 1994; Zhao et al., 1998) . The first phase of the elevation is dependent on Ca 2+ , and is caused by the release of Glu from nerve endings due to Ca 2+ -dependent exocytosis. The second phase is caused by the reversed uptake of Glu by neuronal and/or astrocytic Glu transporters. In the present study, however, the peak of the first phase of the OGD-induced increase in Glu was unclear (Fig. 2) . The OGD-induced rise in Glu during the first 40 min of OGD in cultures incubated in Ca 2+ -free medium was suppressed as compared with that in cultures incubated in normal Ca 2+ -containing medium (Fig. 3E ), although the difference was not significant. In addition, we have previously demonstrated that an OGD insult to neuron/astrocyte co-cultures lasting at least 60-70 min is necessary for the significant induction of PC-induced ischemic tolerance in neurons (Kawahara et al., 2004) . All these findings have led to the hypothesis that the first phase of the OGD-induced rise in Glu has nothing to do with CGD-induced neuronal ischemic tolerance; the second phase seemed critical at least in the cultures used here.
In the brain, at least 40 % of the energy released by respiration is required by 20 Na + /K + -ATPase in order to maintain the ionic gradients of sodium and potassium across cell membranes (Astrup et al., 1981; Hansen, 1985) . Therefore, the sodium pump in the brain requires an enormous expenditure of energy, indicating that the activity of Na + /K + -ATPase is markedly suppressed during ischemia due to a decreased availability of glucose and oxygen (Lees, 1991) . The sodium-dependent astrocytic Glu transporter GLT-1 transports one Glu anion coupled to the co-transport of three Na + and one H + , as well as to the countertransport of one K + (Levy et al., 1998) . GLT-1 uses steep ionic gradients across the membrane to accumulate a high intracellular concentration of Glu in astrocytes. The ionic gradients are mainly maintained by Na + /K + -ATPase, which excludes Na + in exchange for extracellular K + , in turn energizing other secondary ion transporters (e.g., Na + -Ca 2+ exchanger). Thus, in ischemic brain, changing ionic gradients may negate the driving force for Glu uptake, resulting in Glu efflux by the reversed operation of GLT-1. In fact, we have demonstrated that treatment of mixed neuron/astrocyte cultures with ouabain, an inhibitor of Na + /K + -ATPase, results in a reversal of GLT-1 function, and in NMDA receptor-mediated massive neuronal death (Kawahara et al., 2002b) .
Both the neuronal EAAC1 and astrocytic GLAST are sodium-dependent Glu transporters like GLT-1, indicating that OGD-induced disruption of the Na + gradient across the cell membrane is expected to reverse the uptake of Glu by these transporters as well. The present immunocytochemical analysis revealed that GLAST was expressed on astrocytes, although the neuronal EAAC1 was expressed only weakly in the mixed cultures used here (Fig.   3A ). In the present study, the OGD-induced reversed operation of astrocytic GLT-1 seemed to be a primary cause of the marked elevation in the concentration of Glu. In support of this finding, a recent report using rat cerebrocortical prisms has demonstrated that astrocytic GLAST does not contribute to the ischemia-induced rise of extracellular Glu (Nelson et al., 2003) .
In the current study, the rise in extracellular Glu during lethal OGD was markedly suppressed in neuron/astrocyte co-cultures exposed to a sublethal OGD (PC) 24 h before a lethal insult. Provided that the reversed operation of GLT-1 is the primary cause of the increase in Glu during lethal OGD, there is a possibility that the astrocytic expression of GLT-1 is down-regulated on exposure to sublethal OGD (PC). This possibility is now being investigated.
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Figure Legends 
